Randy Scott, Sean George
Invitae President and Chief Operating Officer Sean George will take over as CEO, effective immediately, the company announced. Current CEO Randy Scott will continue full time at Invitae serving as executive chairman of the board of directors. The changes come as the company is focused on driving global growth in genetic testing. Previously, George was a co-founder and CEO of genetic analysis startup Locus Development. Scott previously served as executive chairman at Genomic Health and chief operating officer at personal genomics firm Navigenics.
Francis Ouellette
Génome Québec has appointed Francis Ouellette as VP of scientific affairs. In this role, Ouellette will lead efforts to define the company's vision and develop its scientific strategy. He will start in his new role Feb. 27. Prior to his work with Génome Québec, Ouellette served as associate director of the informatics and biocomputing platform and lead investigator at the Ontario Institute for Cancer Research. He also served as associate professor in the department of medical genetics at the University of British Columbia, director of the UBC Bioinformatics Center at the Michael Smith Laboratories, and coordinated the GenBank database for the US National Institutes of Health.
Mark Adams
Jackson Laboratory has appointed Mark Adams as director of microbial genomic services. In this role, Adams will enhance the organization's large scale microbiome initiatives. Adams joins Jackson Laboratory from the J. Craig Venter Institute, where he directed programs that characterized genomic changes in antibiotic resistance. He also founded the Institute for Genomic Research, co-founded Celera Genomics, and served as associate professor of genetics at Case Western Reserve University.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.